PT80901A - Neue genetische sequenzen die durch sie codierten interferon-peptide von typ i und diese sie produzierende organismen - Google Patents

Neue genetische sequenzen die durch sie codierten interferon-peptide von typ i und diese sie produzierende organismen

Info

Publication number
PT80901A
PT80901A PT80901A PT8090185A PT80901A PT 80901 A PT80901 A PT 80901A PT 80901 A PT80901 A PT 80901A PT 8090185 A PT8090185 A PT 8090185A PT 80901 A PT80901 A PT 80901A
Authority
PT
Portugal
Prior art keywords
organisms
type
cycled
produce
genetic sequences
Prior art date
Application number
PT80901A
Other languages
German (de)
English (en)
Other versions
PT80901B (pt
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/de
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/de
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of PT80901A publication Critical patent/PT80901A/pt
Publication of PT80901B publication Critical patent/PT80901B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT80901A 1984-08-01 1985-08-01 Processo para a preparacao de peptideos interfenona do tipo i codificados por novas sequencias geneticas PT80901B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3428370A DE3428370A1 (de) 1984-08-01 1984-08-01 Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
DE19853505060 DE3505060A1 (de) 1985-02-14 1985-02-14 Neue interferone vom typ i, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen

Publications (2)

Publication Number Publication Date
PT80901A true PT80901A (de) 1985-09-01
PT80901B PT80901B (pt) 1989-01-17

Family

ID=25823496

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80901A PT80901B (pt) 1984-08-01 1985-08-01 Processo para a preparacao de peptideos interfenona do tipo i codificados por novas sequencias geneticas

Country Status (21)

Country Link
EP (1) EP0170204B1 (pt)
JP (2) JP2566909B2 (pt)
KR (1) KR0136799B1 (pt)
AT (1) ATE67786T1 (pt)
AU (1) AU600653B2 (pt)
BG (1) BG60445B2 (pt)
CA (1) CA1340184C (pt)
DD (1) DD246318A5 (pt)
DE (1) DE3584198D1 (pt)
DK (1) DK175194B1 (pt)
ES (2) ES8609475A1 (pt)
FI (1) FI90667C (pt)
GR (1) GR851866B (pt)
HK (1) HK187896A (pt)
HU (1) HU205779B (pt)
IE (1) IE58942B1 (pt)
IL (1) IL75963A (pt)
MX (1) MX9203645A (pt)
NO (1) NO177863C (pt)
NZ (1) NZ212937A (pt)
PT (1) PT80901B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
DE3635867A1 (de) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int Neue hefeexpressionsvektoren fuer ifn-omega, verfahren zu ihrer herstellung und deren verwendung
JP2001523480A (ja) 1997-11-20 2001-11-27 バイカル インコーポレイテッド サイトカイン発現ポリヌクレオチドおよびそれらの組成物を用いた癌の処置
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
DK1481057T3 (da) 2002-03-07 2006-05-15 Eidgenoess Tech Hochschule System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært
JP4727927B2 (ja) * 2002-03-07 2011-07-20 アイトゲネシシェ・テッヒニシェ・ホーホシューレ・チューリッヒ 原核宿主における組換えグリコシル化タンパク質産生のためのシステムおよび方法
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2004096852A1 (fr) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations
ES2535084T3 (es) 2005-05-11 2015-05-05 Eth Zurich Proteínas N-glicosiladas recombinantes procedentes de células procariotas
SI2257307T1 (sl) 2008-02-20 2018-09-28 Glaxosmithkline Biologicals S.A. Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
NO2501406T3 (pt) 2009-11-19 2018-05-19
WO2011138361A1 (en) 2010-05-06 2011-11-10 Glycovaxyn Capsular gram-positive bacteria bioconjugate vaccines
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor

Also Published As

Publication number Publication date
HUT39477A (en) 1986-09-29
FI852956L (fi) 1986-02-02
ES545725A0 (es) 1986-08-01
DE3584198D1 (de) 1991-10-31
FI852956A0 (fi) 1985-07-31
CA1340184C (en) 1998-12-15
GR851866B (pt) 1985-12-02
ES8708013A1 (es) 1987-09-01
JP2566909B2 (ja) 1996-12-25
IL75963A (en) 1992-05-25
KR0136799B1 (ko) 1998-04-25
ES8609475A1 (es) 1986-08-01
ES552431A0 (es) 1987-09-01
HK187896A (en) 1996-10-18
IL75963A0 (en) 1985-12-31
JPS61181381A (ja) 1986-08-14
EP0170204B1 (de) 1991-09-25
DK346385D0 (da) 1985-07-30
IE851906L (en) 1986-02-01
NO853012L (no) 1986-02-03
FI90667C (fi) 1994-03-10
ATE67786T1 (de) 1991-10-15
MX9203645A (es) 1992-09-01
NO177863B (no) 1995-08-28
KR870001310A (ko) 1987-03-13
JP2567195B2 (ja) 1996-12-25
EP0170204A2 (de) 1986-02-05
HU205779B (en) 1992-06-29
DK175194B1 (da) 2004-07-05
NO177863C (no) 1995-12-06
AU600653B2 (en) 1990-08-23
FI90667B (fi) 1993-11-30
NZ212937A (en) 1991-08-27
JPH06181771A (ja) 1994-07-05
PT80901B (pt) 1989-01-17
IE58942B1 (en) 1993-12-01
DD246318A5 (de) 1987-06-03
AU4554985A (en) 1986-02-06
DK346385A (da) 1986-02-02
BG60445B2 (bg) 1995-03-31
EP0170204A3 (en) 1988-02-17

Similar Documents

Publication Publication Date Title
ATE67786T1 (de) Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen.
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
EP0177568A4 (en) RECOMBINANT DNA MOLECULES.
ZA81103B (en) Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
DK1029870T3 (da) Hybride immunglobuliner til anvendelse i terapeutiske fremgangsmåder
DK494681A (da) Femgangsmaade til fremstilling af interferoner
FI873897A7 (fi) Yhdistelmä-DNA-tekniikalla valmistettu ihmisen erytropoietiini.
FI90990B (fi) Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
FI841288A0 (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
ATE35427T1 (de) Rekombinante dna, damit transformierter mikroorganismus und dessen verwendung.
NO950420D0 (no) Interferon endelse derav
DE68910036D1 (de) Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase.
EP0314993A3 (de) 1,7,9,15-Tetraoxa-4,12-diaza-8-silaspiro-[7.7]-pentadecane, Verfahren zu ihrer Herstellung und ihre Verwendung
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same
HRP921091B1 (en) Dna sequences, recombinant dna molecules and processes for producing human fibroplast interferon-like polypeptides
ZA812189B (en) Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides